[Analysis of Experience in Diagnosis and Treatment of Fetal Goiter in Patients with Graves' Disease Complicated with Pregnancy].

S Qin,W J Sun,Y Gao,L X Fan,Y Zhang,J Q Huang,X H Zhang,H X Guo,Huixia Yang
DOI: https://doi.org/10.3760/cma.j.cn112137-20210724-01651
2022-01-01
Abstract:This article reported the clinical diagnosis and treatment experience of two cases of fetal goiter in Graves' disease (GD) complicated with pregnancy. Two GD patients took antithyroid drugs regularly during pregnancy and their thyroid functions were well controlled, but the levels of thyrotropin receptor antibody (TRAb) of the two cases were still above the upper limit in the second and third trimester. Two fetuses had fetal goiter in the middle and late stages of pregnancy. After continuously controlling maternal thyroid function and closely monitoring fetal ultrasound, there was no aggravation of the fetal goiter, and the delivery went smoothly. One case had neonatal hyperthyroidism. It is suggested that although the thyroid function was well controlled during pregnancy in patients with GD, the high level of serum TRAb still needs to be alert to the occurrence of fetal goiter, and fetal ultrasound is the most direct non-invasive monitoring method.
What problem does this paper attempt to address?